Ascentage Pharma Group International American Depository Shares
IPOA Leader in the Discovery and Development of First- and Best-in-class Small Molecule Cancer Therapies -
Public · Suzhou, China · Founded 2009
- Headquarters
- Suzhou
- Employees
- 201–500
- Founded
- 2009
- Business Model
- B2B
- Website
- ascentage.com
- Last Round
- Corporate RoundJun 2024
- Rounds
- 3
- Type
- Public
About
Global integrated biopharmaceutical company discovering, developing, and commercializing first- and best-in-class therapies for unmet medical needs.
Summary
Ascentage Pharma Group International American Depository Shares is a Biotech company based in Suzhou, China, founded in 2009. Its most recent funding was a Corporate Round round in Jun 2024. Investors include Takeda (JP), Future Industry Investment Fund and Oriza Seed Fund.
Tech & App Stack
5 technologies & apps tracked
Create a free account to track companies, build lists, and unlock premium data like the full tech & app stack.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Funding History
Jan 2025
Sign up to see all 5 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Specialty pharmaceutical company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...